ROC analysis to identify sensitivity and specificity of absolute counts of CD19 + CD25+ Bregs or Tregs, serum TGF-β1, or serum IL-10 in identifying CKD (chronic kidney disease) stage 1-3 T in renal transplant recipients. This evidence concerns the gene TGFB1 and chronic kidney disease.